Advertisement

Topics

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

2017-07-24 12:11:38 | BioPortfolio

Published on BioPortfolio: 2017-07-24T12:11:38-0400

Clinical Trials [318 Associated Clinical Trials listed on BioPortfolio]

Dual Algorithm Post Market Clinical Study

The purpose of this study is to assess the validity and reproducibility of the MP Diagnostics HTLV Blot 2.4 in blood specimens testing repeat reactive (RR) on the first FDA licensed screen...

HTLV-1 Carriers and HTLV-1 Associated Illnesses in Blood Donors in Jamaica

RATIONALE: Collecting information about HTLV-1 carriers and HTLV-1 associated illnesses in blood donors in Jamaica may help doctors learn more about these diseases. PURPOSE: This clinical...

A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)

The objective of this study is to assess the efficacy and safety of KW-0761 after intravenous injections in subjects with HTLV-1 associated myelopathy (HAM) in Japan.

Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM)

HTLV-1 Associated Myelopathy is a chronic disease of the spinal cord, caused by a virus called human T lymphotropic virus type 1(HTLV−1). Natural Killer cells provide rapid responses...

Evaluation of InnoLIA HTLV I/II Score

The InnoLIA HTLV I/II Score is an in vitro diagnostic test for confirmation of antibodies to human T-cell lymphotropic virus (HTLV) type I and type II in human blood samples. It is intend...

PubMed Articles [4973 Associated PubMed Articles listed on BioPortfolio]

Hepatitis C viral load in HCV-monoinfected and HCV/HIV-1-, HCV/HTLV-1/-2-, and HCV/HIV/HTLV-1/-2-co-infected patients from São Paulo, Brazil.

Co-infections of hepatitis C virus (HCV) and either human immunodeficiency virus type 1 (HIV-1), human T-cell lymphotropic virus type 1 (HTLV-1) or type 2 (HTLV-2) have been described as having an imp...

Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C.

With this study, the authors hope to alert clinicians regarding the presence of human T-cell lymphotropic virus type 1 and 2 (HTLV-1/-2) infections in patients with viral hepatitis B and C in Brazil. ...

Natural course of HTLV-1 proviral DNA levels in carriers during pregnancy.

The measurement of human T-cell leukemia virus type 1 (HTLV-1) proviral DNA levels using polymerase chain reaction has been beneficial for confirming HTLV-1 infection during pregnancy. However, the in...

Detection of HTLV-1 proviral DNA in BM mononuclear cells and cultured mesenchymal stromal cells isolated from patients with HTLV-1 infection.

The bone marrow (BM) biology during HTLV-1 infection is obscure. In this study, we investigated BM mononuclear cells and mesenchymal stromal cells (MSC) from HTLV-1 asymptomatic and symptomatic indivi...

A 17-Year-Old Boy With Right Face Palsy, Left Leg Weakness, and Lytic Skull-Bone Lesions.

Human T-cell lymphotropic virus (HTLV), an infection that is endemic in certain parts of Asia, Africa, and South America, has been associated with malignancy and neurological deficits. Here, we descri...

Medical and Biotech [MESH] Definitions

Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED).

Antibodies reactive with the HTLV-I ANTIGENS.

Antibodies reactive with the HTLV-II ANTIGENS.

Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.

Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2.

More From BioPortfolio on "MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial